News

ALX Oncology Unveils Promising Data on CD47 and HER2+ Cancer

ALX Oncology Unveils Promising Data on CD47 and HER2+ Cancer

ALX Oncology's Exciting Study Update

ALX Oncology Holdings Inc. (NASDAQ: ALXO), a trailblazer in the biotechnology sector, is making significant strides in cancer treatment through its innovative research. The company recently announced updated findings from the Phase 2 ASPEN-06 trial, which highlight the role of CD47 overexpression as a critical predictive biomarker for patients with HER2-positive gastric cancer.

Understanding the ASPEN-06 Trial

The ASPEN-06 trial is designed to evaluate the effectiveness of ALX Oncology's leading candidate, evorpacept, in combination with HERCEPTIN and CYRAMZA, alongside paclitaxel. This clinical trial aims to explore treatment options for patients suffering from advanced forms of HER2-positive gastric cancer and gastroesophageal junction (GEJ) cancer who have not previously responded to other therapies.

Key Highlights from the Presentation

During the upcoming Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting, ALX Oncology will present crucial data from the trial. The poster presentation will take place on November 8, featuring Dr. Zev A. Wainberg as the first author. The focus will be on how CD47 expression can forecast therapeutic responses to evorpacept, a step forward in personalized medicine.

Trial Details and Patient Enrollment

The ASPEN-06 study is an open-label and randomized trial encompassing a diverse, international patient pool. Specifically, 127 adult patients were enrolled to assess the combination therapy's efficacy, targeting a demographic in dire need of innovative treatment options.

About Evorpacept and Its Potential

Evorpacept stands out as a potential cornerstone therapy in the immune-oncology landscape, signifying ALX Oncology's commitment to advancing patient care. With ongoing trials evaluating its application across various cancer types, evorpacept’s innovative approach could redefine treatment paradigms in oncology.

ALX Oncology's Continuing Journey

As a clinical-stage biotechnology company, ALX Oncology is not only focusing on evorpacept but also exploring other therapeutic candidates in its pipeline, including ALX2004, a unique EGFR-targeted antibody-drug conjugate. This candidate entered clinical trials, showcasing the company’s dedication to expanding its arsenal against cancer.

Building a Community of Hope

ALX Oncology aims to create a community around its research, involving healthcare professionals, patients, and advocates. By actively sharing data and insights, ALX Oncology fosters a collaborative atmosphere that emphasizes improving patient outcomes.

Investing in the Future of Oncology

With robust research initiatives and promising clinical data, ALX Oncology illustrates the vital connection between innovative therapies and patient survival rates. Investors keen on biotechnology advancements will find ALX Oncology's trajectory noteworthy as it continues to unveil critical findings and expand its pipeline.

Frequently Asked Questions

What is the significance of CD47 in the ASPEN-06 trial?

CD47 overexpression serves as a predictive biomarker for therapeutic responses in patients with HER2-positive gastric cancer, crucial for tailoring treatment.

Who is leading the ASPEN-06 trial?

Dr. Zev A. Wainberg, a prominent figure in the oncology field, is the first author of the upcoming presentation on the trial's findings.

What therapies are being evaluated in the ASPEN-06 trial?

The trial focuses on evorpacept in combination with HERCEPTIN, CYRAMZA, and paclitaxel for treating advanced gastric and GEJ cancer.

How many patients were enrolled in the trial?

A total of 127 adult patients participated in the Phase 2 portion of the ASPEN-06 trial.

What other programs is ALX Oncology exploring?

ALX Oncology is advancing not only evorpacept but also ALX2004, an EGFR-targeted antibody-drug conjugate, in clinical trials.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Sitting, Lymph Flow, and a Supplement Maker's Pitch

Updated Category News Views 193

By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...

Continue Reading
PettiChat’s Digital Pet Twin Has Real Consumer Pull

Updated Category News Views 204

A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 175

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 330

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
Ajman Memory Gives Heritage a Durable Digital Backbone

Updated Category News Views 180

Archives usually get applause only after somebody realizes a piece of history has vanished. Ajman is trying to skip that miserable part. During the Ajman Media Forum 2026, held November 18 and 19 at the Emirates Hospitality Centre, the emirate launched Ajman Memory, a project built to collect, document and preserve photographs, papers and video recording its development....

Continue Reading
Newegg’s GIGABYTE Event Is Brand Work, Not a Catalyst

Updated Category News Views 405

A 2,300-square-foot room can tell a retailer plenty about its tribe. On November 21, Newegg is turning its Diamond Bar Gamer Zone into the home base for GIGABYTE’s AORUS VS40 celebration, a free five-hour event marking the hardware maker’s 40th anniversary. There will be 1v1 VALORANT and League of Legends contests, demo stations, raffles, anniversary merchandise, food...

Continue Reading
NatGasHub’s 391% Growth Signals a Real Pipeline Shift

Updated Category News Views 61

Three hundred-plus pipelines is a lot of messy plumbing to tame, and NatGasHub has apparently found a lucrative way to do it. The Houston software company landed at No. 182 on Deloitte’s 2026 Technology Fast 500 after reporting 391% revenue growth from 2022 through 2025. That is a serious number, even in a ranking built to showcase companies sprinting uphill. More...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 182

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 350

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 191

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading

Top 5 Most Recently Viewed Articles

Coloplast A/S Highlights Impressive Full-Year Performance

Updated Category News Views 231

Coloplast A/S Financial Results Overview Coloplast A/S recently announced its full-year financial results for the fiscal year 2023/24, highlighting a solid performance characterized by growth and resilience across various business sectors. Their latest report demonstrates a robust organic growth rate of 8%, coupled with a notable EBIT margin of 27%. In monetary terms, the...

Continue Reading
Introducing Sproutr’s Innovative Program Placement Services

Updated Category News Views 200

Sproutr Unveils Comprehensive Program Placement Services Sproutr, a leading firm in insurance program design and product development, has launched its innovative Program Placement Services. This new offering aims to streamline the entire process of insurance program development, ensuring that it aligns well from the initial design to the final placement with carriers. The...

Continue Reading
Unstoppable Domains Introduces .DEMOS: Redefining Digital Identity

Updated Category News Views 147

Introducing .DEMOS: A New Era of Digital Identity In an exciting development, Unstoppable Domains has rolled out a new top-level domain, .DEMOS, in collaboration with Kynesys.xyz. This innovative domain is positioned as a Web3-first solution designed to foster connection and collaboration in a borderless internet landscape. The name .DEMOS is derived from the Greek term...

Continue Reading
Investors Urged to Join Class Action Against Open Lending Corporation

Updated Category News Views 193

Open Lending Corporation: A Call to Action for Affected Investors Investors suffering heavy losses in Open Lending Corporation (NASDAQ: LPRO) are presented with the chance to take action. It's an opportunity for those impacted by the recent financial discrepancies and corporate disclosures to become lead plaintiffs in a class action lawsuit. Class Action Lawsuit Details...

Continue Reading
McAfee Revolutionizes Digital Security with AI Techniques

Updated Category News Views 253

Innovative Protection: McAfee Leads in AI-Powered Security Recognized as a leader in online security, McAfee has become synonymous with consumer safety in a rapidly evolving digital landscape. With the escalation of online threats, including sophisticated deepfakes and scams, McAfee's advanced artificial intelligence capabilities make it the prime choice for individuals...

Continue Reading